These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30109593)

  • 1. Clinical significance of quantitative assessment of glucose utilization in patients with ischemic cardiomyopathy.
    Ko KY; Wang SY; Yen RF; Shiau YC; Hsu JC; Tsai HY; Lee CL; Chiu KM; Wu YW
    J Nucl Cardiol; 2020 Feb; 27(1):269-279. PubMed ID: 30109593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of quantitative assessment of right ventricular glucose metabolism in patients with heart failure with reduced ejection fraction.
    Tsai SY; Wu YW; Wang SY; Shiau YC; Chiu KM; Tsai HY; Lee CL; Hsu JC; Tu CM; Lin HH; Huang SH
    Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2601-2609. PubMed ID: 31410543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic performance of quantitative PET tools for stratification of patients with ischemic cardiomyopathy undergoing myocardial viability assessment.
    Santana CA; Faber TL; Soler-Peter M; Sanyal R; Esteves FP; Ornelas M; Folks RD; Verdes L; Santana LF; Candell-Riera J; Garcia EV
    Nucl Med Commun; 2008 Nov; 29(11):970-81. PubMed ID: 18836375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
    Visser EP; Philippens ME; Kienhorst L; Kaanders JH; Corstens FH; de Geus-Oei LF; Oyen WJ
    J Nucl Med; 2008 Jun; 49(6):892-8. PubMed ID: 18483085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electromechanical properties of perfusion/metabolism mismatch: comparison of nonfluoroscopic electroanatomic mapping with 18F-FDG PET.
    Graf S; Gyöngyösi M; Khorsand A; Nekolla SG; Pirich C; Kletter K; Dudczak R; Glogar D; Porenta G; Sochor H
    J Nucl Med; 2004 Oct; 45(10):1611-8. PubMed ID: 15471823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of myocardial glucose uptake in patients with ischemic cardiomyopathy: application of a new quantitative method using regional tracer kinetic information.
    Wiggers H; Bøttcher M; Nielsen TT; Gjedde A; Bøtker HE
    J Nucl Med; 1999 Aug; 40(8):1292-300. PubMed ID: 10450680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value and limitation of myocardial fluorodeoxyglucose single photon emission computed tomography using ultra-high energy collimators for assessing myocardial viability.
    Mabuchi M; Kubo N; Morita K; Noriyasu K; Itoh Y; Katoh C; Kuge Y; Tamaki N
    Nucl Med Commun; 2002 Sep; 23(9):879-85. PubMed ID: 12195093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between myocardial blood flow and fasting glucose metabolism in ischemic heart disease. Quantitative assessment by nitrogen-13 ammonia and fluorine-18 fluorodeoxyglucose positron emission tomography.
    Watanabe T; Okazaki O; Akutsu Y; Yamanaka H; Michihata T; Katagiri T; Harumi K
    Jpn Heart J; 1998 May; 39(3):275-85. PubMed ID: 9711179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective analysis of ¹⁸F-FDG PET/CT in patients with uveal melanoma: comparison between metabolic rate of glucose (MRglu) and standardized uptake value (SUV) and correlations with histopathological features.
    Calcagni ML; Mattoli MV; Blasi MA; Petrone G; Sammarco MG; Indovina L; Mulè A; Rufini V; Giordano A
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(11):1682-91. PubMed ID: 23824464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Takotsubo cardiomyopathy: FDG myocardial uptake pattern in fasting patients. Comparison of PET/CT, SPECT, and ECHO results.
    Kobylecka M; Budnik M; Kochanowski J; Piatkowski R; Chojnowski M; Fronczewska-Wieniawska K; Mazurek T; Maczewska J; Peller M; Opolski G; Krolicki L
    J Nucl Cardiol; 2018 Aug; 25(4):1260-1270. PubMed ID: 28054182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of relative 18FDG uptake with metabolic rate (MRGlucose) in the myocardium in CAD, classified by 99m-Tc-MIBI].
    Büll U; Foroutan Y; Hellwig D; Kaiser HJ; Schulz G; Sabri O; Schreckenberger M; vom Dahl J
    Nuklearmedizin; 1995 Dec; 34(6):223-8. PubMed ID: 8596738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of CT attenuation correction on the viability pattern assessed by 99mTc-tetrofosmin SPECT/ 18F-FDG PET.
    Nkoulou R; Pazhenkottil AP; Buechel RR; Husmann L; Valenta I; Herzog BA; Wolfrum M; Ghadri JR; Kaufmann PA
    Int J Cardiovasc Imaging; 2011 Jul; 27(6):913-21. PubMed ID: 20931288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of myocardial 18F-fluorodeoxyglucose positron emission computed tomography in dilated cardiomyopathy and ischemic cardiomyopathy.
    Yamaguchi H; Hasegawa S; Yoshioka J; Uehara T; Hashimoto K; Kusuoka H; Kuzuya T; Hori M; Nishimura T
    Ann Nucl Med; 2000 Feb; 14(1):33-8. PubMed ID: 10770578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18-Fluorodeoxyglucose imaging with positron emission tomography and single photon emission computed tomography: cardiac applications.
    Bax JJ; Patton JA; Poldermans D; Elhendy A; Sandler MP
    Semin Nucl Med; 2000 Oct; 30(4):281-98. PubMed ID: 11105929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-deoxyglucose and the assessment of myocardial viability.
    Schelbert HR
    Semin Nucl Med; 2002 Jan; 32(1):60-9. PubMed ID: 11839071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective Evaluation of 18F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging as a Prognostic Marker of Functional Outcome.
    Rischpler C; Dirschinger RJ; Nekolla SG; Kossmann H; Nicolosi S; Hanus F; van Marwick S; Kunze KP; Meinicke A; Götze K; Kastrati A; Langwieser N; Ibrahim T; Nahrendorf M; Schwaiger M; Laugwitz KL
    Circ Cardiovasc Imaging; 2016 Apr; 9(4):e004316. PubMed ID: 27056601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined study with FDG PET and Tl SPECT in patients with idiopathic dilated cardiomyopathy.
    Isobe S; Ando A; Nanasato M; Nonokawa M; Izawa H; Sobue T; Hirai M; Ito K; Ishigaki T; Murohara T; Yokota M
    Nucl Med Commun; 2003 Oct; 24(10):1071-80. PubMed ID: 14508163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hibernating myocardium and the 'no reflow' phenomenon: a study of absolute regional myocardial perfusion and glucose metabolism using positron emission tomography in chronic and acute heart disorders].
    Maes A; Nuyts J
    Verh K Acad Geneeskd Belg; 1997; 59(3):133-60. PubMed ID: 9490915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental study on "ischemic memory" of myocardium with different ischemic degrees by
    Li J; Zheng N; Zhang G; Bao B; Liu L; Hao L; Wang X
    Ann Nucl Med; 2020 Jan; 34(1):24-30. PubMed ID: 31637598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.